Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Why does heart failure matter?

Written by | 4 Jul 2023

A recent publication described the holistic approach to drug therapy in a patient with heart failure – an area where treatment has changed considerably over the past 30… read more.

Prescribing of key heart failure medications improved with tailored digital alerts

Written by | 21 Jun 2023

Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 times as likely to prescribe mineralocorticoid receptor antagonists (MRAs), a guideline-recommended class of heart… read more.

Bayer starts phase II/III study with vericiguat in children with heart failure

Written by | 19 Jun 2023

Bayer and its development partner MSD (a tradename of Merck & Co., Inc., Rahway, NJ, USA) announced that the first patient has been enrolled in the Phase II/III… read more.

FDA approval for Inpefa to treat heart failure – Lexicon Pharma

Written by | 3 Jun 2023

Lexicon Pharmaceuticals, Inc. announced that the FDA has approved Inpefa (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent… read more.

Hunger hormone could help patients with heart failure

Written by | 16 Mar 2023

The hunger hormone ghrelin appears to increase pumping capacity in patients with heart failure, researchers reported on March 14, 2023 in European Heart Journal. “Heart failure is the… read more.

NICE Quality Standards for managing chronic heart failure

Written by | 10 Mar 2023

Dr Rani Khatib is a Consultant Cardiology Pharmacist at Leeds Teaching Hospitals NHS Trust and Associate Professor at the Leeds Institute for Cardiometabolic Medicine (LICaM), University of Leeds. As… read more.

What are the implications of the NICE Quality Standards?

Written by | 9 Mar 2023

The updated and expanded NICE quality standards should be used in all care settings to audit and improve services for people with chronic heart failure, according to Dr… read more.

Why do we need NICE Quality Standards for chronic heart failure?

Written by | 8 Mar 2023

Dr Rani Khatib is a consultant pharmacist in cardiology and cardiovascular research and associate professor at the University of Leeds. As a member of the NICE Guideline Development… read more.

Alert banners dramatically increase prescribing rates of life-saving heart failure medication

Written by | 7 Mar 2023

An automated system that flags which patients could most benefit from an underused yet life-saving cardiology drug more than doubled new prescriptions, according to a pilot program test… read more.

Donor hearts can be reprogrammed with medication for longer storage, improved transplant outcomes

Written by | 16 Feb 2023

Hundreds of thousands of Americans with heart failure are sick enough to benefit from a transplant, yet only around 4,000 heart transplants are performed annually. One reason for… read more.

Dapagliflozin improves outcomes in heart failure among frail patients

Written by | 27 Apr 2022

Adjunctive dapagliflozin therapy appears to improve outcomes in heart failure patients without regard to frailty status at initiation of treatment. These findings appeared on April 26, 2022 in… read more.

Pilot study suggests artificial intelligence could help assess, improve heart transplant outcomes

Written by | 22 Mar 2022

Heart transplantation can be a lifesaving operation for patients with end-stage heart failure. However, many patients experience organ transplant rejection, in which the immune system begins attacking the… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.